Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study
(2022)
Journal Article
Henze, L., Foth, S., Meller, S., Twele, F., Charalambous, M., Kenward, H., Elliott, J., Pelligand, L., & Volk, H. (2022). Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study. Journal of Veterinary Internal Medicine, https://doi.org/10.1111/jvim.16504
Background: Nausea and emesis can be, among other signs, common manifestations
of acute vestibular system dysfunction in dogs. Currently, antiemetic drugs, such as
maropitant and metoclopramide, are used commonly, but do not appear to control
naus...
Read More about Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.